Organizer Profile
Memorial Sloan Kettering Cancer Center (MSKCC)

Memorial Sloan Kettering Cancer Center (MSKCC)

New York City, New York, United States of America

Memorial Sloan Kettering Cancer Center the world’s oldest and largest private cancer center has devoted more than 135 years to exceptional patient care, innovative research, and outstanding educational programs. Today, they are one of 51 National Cancer Institute–designated Comprehensive Cancer Centers, with state-of-the-art science flourishing side by side with clinical studies and treatment. The close collaboration between our physicians and scientists is one of their unique strengths, enabling us to provide patients with the best care available as they work to discover more-effective strategies to prevent, control, and ultimately cure cancer in the future.

 

The goal of Memorial Sloan Kettering's Continuing Medical Education (MSK CME) program is to disseminate current and new knowledge of the etiology, prevention, diagnosis and treatment of cancer, and allied diseases in order to improve competence. The offerings are also intended to enhance the training of physicians and other healthcare professionals. The content of the activities is designed to include new research findings, clinical knowledge, and treatment modalities and their applications to various types and stages of cancer and allied diseases.

CONFERENCES AND COURSES

Gamma delta T cell profiling in a cohort of preterm infants reveals elevated frequencies of CD83+ Gamma delta T cells in sepsis
  • Journal CME-0 Journal CME
  • Speciality Allergy and Immunology, Pediatric Hematology and Bone Marrow Transplant ...
  • Calendar May 16, 2024 - Jul 16, 2027
High burden of viruses and bacterial pathobionts drives heightened nasal innate immunity in children
  • Journal CME-1 Journal CME
  • Speciality Allergy and Immunology, Pediatric Hematology and Bone Marrow Transplant ...
  • Calendar Jul 01, 2024 - Jul 01, 2027
Journal Based CME: Helper T 1 cell immunity in humans with inherited CD4 deficiency
  • Journal CME-2 Journal CME
  • Speciality Allergy and Immunology, Hematology Blood and Marrow Transplant ...
  • Calendar Apr 01, 2024 - Apr 01, 2027
Journal-Based CME: First-in-human therapy with Treg produced from thymic tissue (thyTreg) in a heart transplant infant
  • Journal CME-3 Journal CME
  • Speciality Allergy and Immunology, Pediatric Hematology and Bone Marrow Transplant ...
  • Calendar Oct 31, 2024 - Oct 31, 2026
Journal-Based CME: The PML hub: An emerging actor of leukemia therapies
  • Journal CME-4 Journal CME
  • Speciality General Practice, Family Practice ...
  • Calendar Jun 29, 2023 - Jun 29, 2026
Journal-Based CME: Neutrophil extracellular traps and extracellular histones potentiate IL-17 inflammation in periodontitis
  • Journal CME-5 Journal CME
  • Speciality Allergy and Immunology, General Practice ...
  • Calendar Jun 01, 2023 - Jun 01, 2026
Journal-Based CME: SARS-CoV-2 infection and recovery in children: distinct T cell responses in MIS-C compared to COVID-19
  • Journal CME-6 Journal CME
  • Speciality Allergy and Immunology, Cardiology ...
  • Calendar May 03, 2023 - May 03, 2026
Journal-Based CME: MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition
  • Journal CME-7 Journal CME
  • Speciality Surgical Oncology, Oncology ...
  • Calendar Jan 19, 2023 - Jan 19, 2026
Journal-Based CME: Microbiome influencers of checkpoint blockade–associated toxicity
  • Journal CME-8 Journal CME
  • Speciality Allergy and Immunology, Cosmetic Breast Surgery ...
  • Calendar Jan 09, 2023 - Jan 09, 2026